Global Wound & Tissue Care Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2025

The global wound & tissue care market was valued at USD 29,336.4 mn in 2018 and is expected to reach USD 44,991.9 mn by 2025 at a CAGR of 6.3% during the forecast period.The global wound & tissue care market is witnessing growth due to increasing prevalence of diabetes, rapid growth in geriatric population, developments and innovations in wound care products, increasing funding for wound care research, and awareness programs for wound care treatment and management.

Click here to download report sample-https://www.supplydemandmarketresearch.com/home/contact/849137?ref=Sample-and-Brochure&toccode=SDMRHE849137

Chronic conditions such as diabetic foot ulcers that are not healed and venous leg ulcers are a tremendous burden on the health care system. While a little over half of diabetic foot ulcers will cure within 12 weeks, a year after occurrence, 13 percent will stay unhealed. Medicare recipients with diabetic foot ulcers are seen approximately 12 times a year by their outpatient health care providers and they are hospitalized approximately twice a year. Approximately 1 million Americans face diabetic foot ulcers every year, equivalent to more than USD 15 billion in annual healthcare spending. Additionally, more than three million Americans experience venous leg ulcer each year, adding an additional USD 2 billion or more to the nation's healthcare expenditure.

Click here at avail 10% discount@https://www.supplydemandmarketresearch.com/home/contact/849137?ref=Discount&toccode=SDMRHE849137

In 2018, surgical applications accounted for more than 60% of overall market share and are expected to grow at a CAGR of 6.5% over the forecast period.North America to dominate the wound & tissue market throughout the forecast periodThe North America wound & tissue care market size is expected to grow at a CAGR of 6.2% over the forecast period. Leading wound care companies operating in North America are Ethicon, Acelity, Medtronic, Cardinal Health, Medline, Baxter, 3M, Integra LifeSciences, MiMedx, and M�lnlycke. The increasing prevalence of diabetes, ulcers, and other chronic diseases is expected to propel the wound care market in this region. Additionally, the growing aging population will further create demand for wound & tissue care services in the coming years.

Company Profiles and Competitive Intelligence
The major players operating in the global wound & tissue care market are 3M, ABL Medical, Acelity, ACell, AquaMed, Amniox Medical, Inc, Angelini, Argentum Medical, LLC, ArjoHuntleigh, Arobella Medical, LLC, Baxter International Inc., Aesculap, Inc. - B. Braun, Cardinal Health, Coloplast A/S, ConvaTec, Inc, and other notable players.

Table of Content (TOC)
Chapter 1Executive Summary
1.1Global Wound & Tissue Care market overview
1.2Wound & Tissue Care Segment by Type
1.2.1Traditional adhesive bandages
1.2.2Negative pressure wound therapy
1.2.3Antimicrobial dressings
1.2.4Traditional gauze bandages
1.2.5Foam dressings
1.2.6Non-adherent bandages
1.2.7Hydrocolloids
1.2.8Film dressings
1.2.9Growth factors
1.2.10Bioengineered skin
1.3Wound & Tissue Care Segment by Application
1.3.1Surgical
1.3.2Trauma/Lacerations
1.3.3Burns
1.3.4Pressure ulcer
1.3.5Venous ulcer
1.3.6Diabetic ulcer
1.4Global Wound & Tissue Care Market by Region
1.4.1North America
1.4.2Europe
1.4.3China
1.4.4Japan
1.5Global Wound & Tissue Care Market Size
1.5.1Global Wound & Tissue Care Revenue (2014-2025)

Chapter 2Global Wound & Tissue Care Market Competition by Manufacturers
2.1Global Wound & Tissue Care Revenue Share by Manufacturers, 2018
2.2Manufacturers Wound & Tissue Care Sites, Area Served, Product Types
2.3Wound & Tissue Care Market Competitive Situation and Trends
2.3.1Wound & Tissue Care Market Concentration Rate
2.3.2Wound & Tissue Care Market Share of Top 3 and Top 5 Manufacturers
2.3.3Mergers & Acquisitions, Expansion, New product development

Chapter 3Company Profiles - Wound & Tissue Care Business
3.13M
3.1.1Company overview
3.1.2Product offerings
3.1.3Financial performance
3.1.4Recent developments
3.2ABL Medical
3.2.1Company overview
3.2.2Product offerings
3.3Acelity
3.3.1Company overview
3.3.2Product offerings
3.3.3Financial performance
3.3.4Recent developments
3.4ACell
3.4.1Company overview
3.4.2Product offerings
3.4.3Financial performance
3.5AquaMed - Alliqua BioMedical
3.5.1Company overview
3.5.2Product offerings
3.5.3Financial performance
3.6Amniox Medical, Inc.
3.6.1Company overview
3.6.2Product offerings
3.6.3Financial performance
3.7Angelini
3.7.1Company overview
3.7.2Product offerings
3.7.3Financial performance
3.8Argentum Medical, LLC
3.8.1Company overview
3.8.2Product offerings
3.8.3Financial performance
3.9ArjoHuntleigh
3.9.1Company overview
3.9.2Product offerings
3.9.3Financial performance
3.10Arobella Medical, LLC
3.10.1Company overview
3.10.2Product offerings
3.10.3Financial performance
3.11Baxter International Inc.
3.11.1Company overview
3.11.2Product offerings
3.11.3Financial performance
3.11.4Recent developments
3.12Aesculap, Inc. - B. Braun
3.12.1Company overview
3.12.2Product offerings
3.12.3Financial performance
3.13Cardinal Health
3.13.1Company overview
3.13.2Product offerings
3.13.3Financial performance to be continued on https://www.supplydemandmarketresearch.com/home/toc_publisher/849137?code=SDMRHE849137

Nimesh H
302-20 Misssisauga Valley, Missisauga,
L5A 3S1, Toronto, Canada
Global +1-276-477-5910
Email info@supplydemandmarketresearch.com

SupplyDemandMarketResearch.com have a strong network of high powered and experienced global consultants who have about 10+ years of experience in the specific industry to deliver quality research and analysis. Having such an experienced network, our services not only cater to the client who wants the basic reference of market numbers and related high growth areas in the demand side, but also we provide detailed and granular information using which the client can definitely plan the strategies with respect to both supply and demand side.

This release was published on openPR.